Award recordCONTRACT

AMICUS THERAPEUTICS US, LLC

PIID 36C25926F0001· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $295,018 net obligations· UEI KLJFGENKMD89· PA

Description

GALAFOLD 123 MG CAPSULE - NTE

First action · last action
2025-11-13 · 2026-01-30
Transactions
2
First transaction's obligation
$284,586
Base + all options value (sum of deltas)
$295,018
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79724D0185
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$295,018$0Base award · 2025-11-13 · this action $284,586 · running total $284,586Modification P00001 · 2026-01-30 · this action $10,432 · running total $295,018
  • Base2025-11-13+$284,586= $284,586
  • Mod P000012026-01-30+$10,432= $295,018
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-11-13+$284,586$284,586GALAFOLD 123 MG CAPSULE - NTE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-01-30+$10,432$295,018GALAFOLD 123 MG CAPSULE - NTE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KLJFGENKMD89)

AwardOffice · PSC / listingNet obligationsFY
36C24926N0676249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$68,519FY2026
36C24526F0342245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,840FY2026
36C24526N0706245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,840FY2026
36C24526N0621245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,840FY2026
36C24926F0155249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$68,519FY2026
36C26126F0214261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$22,840FY2026

Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926F0310JANSSEN BIOTECH INCNETWORK CONTRACT OFFICE 19 (36C259)$384,719FY2026
36C25926N0409MEDI-PHYSICS, INC.NETWORK CONTRACT OFFICE 19 (36C259)$34,735FY2026
36C25926F0264JANSSEN BIOTECH INCNETWORK CONTRACT OFFICE 19 (36C259)$384,719FY2026
36C25926N0384SIRTEX MEDICAL INCNETWORK CONTRACT OFFICE 19 (36C259)$245,194FY2026
36C25926P0553COSETTE PHARMACEUTICALS, INC.NETWORK CONTRACT OFFICE 19 (36C259)$3,439FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25926F0001_3600_36F79724D0185_3600 · retrieved 2026-09-26.